4Aoyagi M,Fukai N,Yamamoto M,et al.Early Development of Intimal Thickening in Superficial Temporal Arteries in Patients With Moyamoya Disease.Stroke,1996,27(10):1750-1754..
5Suzuki Y,Fujita M,Mizutani N,et al.Role of nitric oxide in the control of cerebral microcirculation under physiological and pathological condition.Clinical Hemorheology Microcirculation,2000,23(2-4):307-312.
6Noda A,Suzuki Y,Takayasu M,et al.Elevation of nitric oxide metabolites in the cerebrospinal fluid of patients with Moyamoya disease.Acta Neurochir(Wien),2000,142(11):1275-1280.
7Hoshimaru M,Takahashi JA,Kikuchi H,et al.Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease:an immunohistochemical study.J Neurosurg,1991,75(2):267-270.
8Suzui H,Hoshimaru M,Takahashi JA,et al.Immunohistochemical reactions for fibroblast growth factor receptor in arteries of patients with Moyamoya disease.Neutosurgery,1994,35(1):20-25.
9Takahashi A,Sawamura Y,Houkin K,et al.The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor.Neurosci Lett,1993,160(2):214-216.
10Yoshimoto T,Houkin K,Takahashi A,et al.Angiogenic factors in moyamoya disease.Stroke,1996,27(12):2160-2165.
6Hune S Y,DeVeber G A,MacGregor D L,et al.Nursing Issues in Caring for Children with Moyamoya Vasculopathy and Their Families[J].J Neurosci Nurs,2007,39(1):33-39.
